Artsen willen betere etikettering van biosimilars

European physicians want more information in the biosimilar label than is currently available, according to a new study initiated and supported by EuropaBio.
When comparing a standard label of an authorized biosimilar with a label containing additional relevant information, 83% of physicians preferred the one with additional information about what data had been generated with which product, according to a press release. In addition, 91% said that they use the label frequently or occasionally as a source of information and 87% said it was helpful, or very helpful, to include a clear statement on the origin of the biosimilar’s data on the label (Healthcare Packaging, 19 april 2016).
Klik hier voor het oorspronkelijke nieuwsbericht.
Klik hier voor het onderzoeksartikel in Regular Toxicology and Pharmacology.
Klik hier voor meer informatie over de module Pharmaceutical packaging regulations van de NVC E-Course Pharmaceutical Packaging.

Heeft u vragen over dit onderwerp, neem dan contact met ons op via e-mail of bel: +31-(0)182-512411. Dit bericht is ook opgenomen in ons maandelijkse overzicht, de NVC Members-only Update.